Introduction Oral corticosteroids (OCS) for asthma are associated with increased risks of developing adverse outcomes (adverse outcomes); no previous study has focused exclusively on intermittent OCS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback